CoChat

Automation, Monitoring, and Standardization of Cell Product Manufacturing

Doulgkeroglou, Meletios-Nikolaos, Di Nubila, Alessia, Niessing, Bastian, König, Niels, Schmitt, Robert H., Damen, Jackie, Szilvassy, Stephen J., Chang, Wing, Csontos, Lynn, Louis, Sharon, Kugelmeier, Patrick, Ronfard, Vincent, Bayon, Yves, Zeugolis, Dimitrios I. · 2020 · Frontiers in Bioengineering and Biotechnology
Cited by 98

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Although regenerative medicine products are at the forefront of scientific research, technological innovation, and clinical translation, their reproducibility and large-scale production are compromised by automation, monitoring, and standardization issues. To overcome these limitations, new technologies at software (e.g., algorithms and artificial intelligence models, combined with imaging software and machine learning techniques) and hardware (e.g., automated liquid handling, automated cell expansion bioreactor systems, automated colony-forming unit counting and characterization units, and scalable cell culture plates) level are under intense investigation. Automation, monitoring and standardization should be considered at the early stages of the developmental cycle of cell products to deliver more robust and effective therapies and treatment plans to the bedside, reducing healthcare expenditure and improving services and patient care.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fbioe.2020.00811

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 95

  1. Abreu, 2019, Current challenges and emerging opportunities of CAR-T cell therapies., J. Control. Release, 319, 246, 10.1016/j.jconrel.2019.12.047 · DOI
  2. Aijaz, 2018, Biomanufacturing for clinically advanced cell therapies., Nat. Biomed. Eng., 2, 362, 10.1038/s41551-018-0246-6 · DOI · Paper page
  3. Anitha, 2020, Tissue-engineered islet-like cell clusters generated from adipose tissue-derived stem cells on three-dimensional electrospun scaffolds can reverse diabetes in an experimental rat model and the role of porosity of scaffolds on cluster differentiation., J. Biomed. Mater. Res. A, 108, 749, 10.1002/jbm.a.36854 · doi:10.1002/jbm.a.36854
  4. Ball, 2018, Bioprocessing automation in cell therapy manufacturing: outcomes of special interest group automation workshop., Cytotherapy, 20, 592, 10.1016/j.jcyt.2018.01.005 · doi:10.1016/j.jcyt.2018.01.005
  5. Bhang, 2012, Transplantation of cord blood mesenchymal stem cells as spheroids enhances vascularization., Tissue Eng. A, 18, 2138, 10.1089/ten.tea.2011.0640 · DOI · Paper page
  6. Boutros, 2015, Microscopy-based high-content screening., Cell, 163, 1314, 10.1016/j.cell.2015.11.007 · DOI · Paper page
  7. Boyer, 2018, High-throughput scaffold-free microtissues through 3D printing., 3D Print. Med., 4, 10.1186/s41205-018-0029-4 · DOI
  8. Brandhorst, 2016, High seeding density induces local hypoxia and triggers a proinflammatory response in isolated human islets., Cell Transplant., 25, 1539, 10.3727/096368915x689929 · DOI
  9. Buskermolen, 2018, An automated quantitative analysis of cell, nucleus and focal adhesion morphology., PLoS One, 13, 10.1371/journal.pone.0195201 · DOI
  10. Cesarz, 2016, Spheroid culture of mesenchymal stem cells., Stem Cells Int., 2016, 10.1155/2016/9176357 · DOI · Paper page
  11. Chang, 2018, Crosslinked chitosan-PEG hydrogel for culture of human glioblastoma cell spheroids and drug screening., Adv. Ther., 1, 10.1002/adtp.201800058 · DOI
  12. Chatzinikolaidou, 2016, Cell spheroids: the new frontiers in in vitro models for cancer drug validation., Drug Discov. Today, 21, 1553, 10.1016/j.drudis.2016.06.024 · DOI
  13. Cierpka-Kmiec, 2019, In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cells., Folia Histochem. Cytobiol., 57, 1
  14. Cigognini, 2013, Engineering in vitro microenvironments for cell based therapies and drug discovery., Drug Discov. Today, 18, 1099, 10.1016/j.drudis.2013.06.007 · DOI
  15. Colle, 2020, Bioprinting predifferentiated adipose-derived mesenchymal stem cell spheroids with methacrylated gelatin ink for adipose tissue engineering., J. Mater. Sci. Mater. Med., 31, 10.1007/s10856-020-06374-w · DOI
  16. Costariol, 2019, Establishing the scalable manufacture of primary human T-cells in an automated stirred-tank bioreactor., Biotechnol. Bioeng., 116, 2488, 10.1002/bit.27088 · DOI · Paper page
  17. de Sousa Pinto, 2019, Scalable manufacturing of human mesenchymal stromal cells in the vertical-wheel bioreactor system: an experimental and economic approach., Biotechnol. J., 14, 10.1002/biot.201800716 · DOI
  18. DeFilipp, 2019, Hematopoietic cell transplantation in the treatment of adult acute lymphoblastic leukemia: updated 2019 evidence-based review from the American Society for Transplantation and Cellular Therapy., Biol. Blood Marrow Transplant., 25, 2113, 10.1016/j.bbmt.2019.08.014 · DOI
  19. Fu, 2013, Regulation of insulin synthesis and secretion and pancreatic beta-cell dysfunction in diabetes., Curr. Diabetes Rev., 9, 25, 10.2174/157339913804143225 · DOI · Paper page
  20. 2018, Cell Therapy Market Size, Share, & Trends Analysis Report by Use (Clinical, Research), by Type (Stem & Non-Stem Cells) by Therapy Type (Autologous, Allogenic), by Region, and Segment Forecasts, 2018 –2025.
  21. Gutzweiler, 2017, Large scale production and controlled deposition of single HUVEC spheroids for bioprinting applications., Biofabrication, 9, 10.1088/1758-5090/aa7218 · DOI
  22. Hagemann, 2017, Spheroid-based 3D cell cultures enable personalized therapy testing and drug discovery in head and neck cancer., Anticancer Res., 37, 2201, 10.21873/anticanres.11555 · DOI · Paper page
  23. Harrison, Cell therapy-processing economics: small-scale microfactories as a stepping stone toward large-scale macrofactories., Regen. Med., 13, 159, 10.2217/rme-2017-0103 · DOI
  24. Harrison, Decentralised manufacturing of cell and gene therapy products: learning from other healthcare sectors., Biotechnol. Adv., 36, 345, 10.1016/j.biotechadv.2017.12.013 · DOI · Paper page
  25. Hunsberger, 2018, An industry-driven roadmap for manufacturing in regenerative medicine., Stem Cells Transl. Med., 7, 564, 10.1002/sctm.18-0060 · DOI · Paper page
  26. Ichihara, 2016, Size effect of engineered islets prepared using microfabricated wells on islet cell function and arrangement., Heliyon, 2, 10.1016/j.heliyon.2016.e00129 · DOI
  27. Jung, 2018, Highly modular and generic control software for adaptive cell processing on automated production platforms., Procedia CIRP, 72, 1245, 10.1016/j.procir.2018.03.189 · DOI
  28. Juric, 2016, Milestones of hematopoietic stem cell transplantation - From first human studies to current developments., Front. Immunol., 7, 10.3389/fimmu.2016.00470 · DOI
  29. Kanafi, 2013, Transplantation of islet-like cell clusters derived from human dental pulp stem cells restores normoglycemia in diabetic mice., Cytotherapy, 15, 1228, 10.1016/j.jcyt.2013.05.008 · DOI
  30. Kapur, 2012, Human adipose stem cells maintain proliferative, synthetic and multipotential properties when suspension cultured as self-assembling spheroids., Biofabrication, 4, 10.1088/1758-5082/4/2/025004 · DOI
  31. Kettunen, 2020, Human physiology of genetic defects causing beta-cell dysfunction., J. Mol. Biol., 432, 1579, 10.1016/j.jmb.2019.12.038 · DOI
  32. Kim, 2019, Fabrication of core-shell spheroids as building blocks for engineering 3D complex vascularized tissue., Acta Biomater., 100, 158, 10.1016/j.actbio.2019.09.028 · DOI
  33. Kong, 2012, Automatic liquid handling for life science: a critical review of the current state of the art., J. Lab. Autom., 17, 169, 10.1177/2211068211435302 · DOI · Paper page
  34. Kumar, 2019, Applications of stem cells and bioprinting for potential treatment of diabetes., World J. Stem Cells, 11, 13, 10.4252/wjsc.v11.i1.13 · DOI
  35. Labuschagne, 2019, Cell clustering promotes a metabolic switch that supports metastatic colonization., Cell Metab., 30, 720, 10.1016/j.cmet.2019.07.014 · DOI · Paper page
  36. Lam, 2019, Machine learning with optical phase signatures for phenotypic profiling of cell lines., Cytometry A, 95, 757, 10.1002/cyto.a.23774 · DOI
  37. Langer, 2020, Rapid production and recovery of cell spheroids by automated droplet microfluidics., SLAS Technol., 25, 111, 10.1177/2472630319877376 · DOI
  38. Lee, 2018, Generation of uniform-sized multicellular tumor spheroids using hydrogel microwells for advanced drug screening., Sci. Rep., 8, 10.1038/s41598-018-35216-7 · DOI · Paper page
  39. Lehmann, 2016, Biomek cell workstation: a variable system for automated cell cultivation., J. Lab. Autom., 21, 439, 10.1177/2211068215599786 · DOI
  40. Lehmann, 2007, Superiority of small islets in human islet transplantation., Diabetes Metab. Res. Rev., 56, 594
  41. Lilly, 2016, Current stem cell based therapies in diabetes., Am. J. Stem Cells, 5, 87
  42. Lippi, 2017, Estimating the intra- and inter-individual imprecision of manual pipetting., Clin. Chem. Lab. Med., 55, 962, 10.1515/cclm-2016-0810 · DOI
  43. Lipsitz, 2017, A roadmap for cost-of-goods planning to guide economic production of cell therapy products., Cytotherapy, 19, 1383, 10.1016/j.jcyt.2017.06.009 · DOI
  44. Liu, 2017, Nano-on-micro fibrous extracellular matrices for scalable expansion of human ES/iPS cells., Biomaterials, 124, 47, 10.1016/j.biomaterials.2017.01.039 · DOI
  45. Lo, 2019, Growing human dermal fibroblasts as spheroids renders them susceptible for early expression of pluripotency genes., Adv. Biosyst., 3, 10.1002/adbi.201900094 · DOI
  46. Logan, 2016, Quantifying co-cultured cell phenotypes in high-throughput using pixel-based classification., Methods, 96, 6, 10.1016/j.ymeth.2015.12.002 · DOI
  47. Ly, 2013, Automated reagent-dispensing system for microfluidic cell biology assays., J. Lab. Autom., 18, 530, 10.1177/2211068213504758 · doi:10.1177/2211068213504758
  48. Maddah, 2014, A system for automated, noninvasive, morphology-based evaluation of induced pluripotent stem cell cultures., J. Lab. Autom., 19, 454, 10.1177/2211068214537258 · DOI
  49. Marshall, 2014, Preventing kidney failure in people with diabetes., Diabet. Med., 31, 1280, 10.1111/dme.12535 · DOI
  50. Mehrian, 2020, Predicting in vitro human mesenchymal stromal cell expansion based on individual donor characteristics using machine learning., Cytotherapy, 22, 82, 10.1016/j.jcyt.2019.12.006 · DOI
  51. Mitchell, 2017, Reproducing cells is nothing new—A historical perspective, Bioprinting: Techniques and Risks for Regenerative Medicine, 10.1016/B978-0-12-805369-0.00002-X · DOI
  52. Miyamoto, 2017, Enhanced adipogenic differentiation of human adipose-derived stem cells in an in vitro microenvironment: the preparation of adipose-like microtissues using a three-dimensional culture., Cell Med., 9, 35, 10.3727/215517916X693096 · DOI
  53. Moritani, 2018, Spheroid culture enhances osteogenic potential of periodontal ligament mesenchymal stem cells., J. Periodontal Res., 53, 870, 10.1111/jre.12577 · DOI
  54. Moritz, 2002, Apoptosis in hypoxic human pancreatic islets correlates with HIF-1α expression., FASEB J., 16, 745, 10.1096/fj.01-0403fje · DOI · Paper page
  55. Morrow, 2017, Addressing pressing needs in the development of advanced therapies., Front. Bioeng. Biotechnol., 5, 10.3389/fbioe.2017.00055 · doi:10.3389/fbioe.2017.00055
  56. Moutsatsou, 2019, Automation in cell and gene therapy manufacturing: from past to future., Biotechnol. Lett., 41, 1245, 10.1007/s10529-019-02732-z · DOI · Paper page
  57. Murphy, 2014, Human mesenchymal stem cell spheroids in fibrin hydrogels exhibit improved cell survival and potential for bone healing., Cell Tissue Res., 357, 91, 10.1007/s00441-014-1830-z · DOI
  58. Nagasaka, 2017, Image-based cell quality evaluation to detect irregularities under same culture process of human induced pluripotent stem cells., J. Biosci. Bioeng., 123, 642, 10.1016/j.jbiosc.2016.12.015 · doi:10.1016/j.jbiosc.2016.12.015
  59. Naldini, 2019, Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives., EMBO Mol. Med., 11, 10.15252/emmm.201809958 · DOI · Paper page
  60. Oh, 2018, Highly angiogenic, nonthrombogenic bone marrow mononuclear cell-derived spheroids in intraportal islet transplantation., Diabetes Metab. Res. Rev., 67, 473
  61. Ong, 2018, In vivo therapeutic applications of cell spheroids., Biotechnol. Adv., 36, 494, 10.1016/j.biotechadv.2018.02.003 · DOI
  62. Orita, 2019, Deep learning-based quality control of cultured human-induced pluripotent stem cell-derived cardiomyocytes., J. Pharmacol. Sci., 140, 313, 10.1016/j.jphs.2019.04.008 · DOI
  63. Page, 2011, Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants., Biol. Blood Marrow Transplant., 17, 1362, 10.1016/j.bbmt.2011.01.011 · DOI · Paper page
  64. Pamphilon, 2013, Current practices and prospects for standardization of the hematopoietic colony-forming unit assay: a report by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative., Cytotherapy, 15, 255, 10.1016/j.jcyt.2012.11.013 · doi:10.1016/j.jcyt.2012.11.013
  65. Papas, 2019, Oxygenation strategies for encapsulated islet and beta cell transplants., Adv. Drug Deliv. Rev., 139, 139, 10.1016/j.addr.2019.05.002 · DOI · Paper page
  66. Peddi, 2007, High-throughput automated system for crystallizing membrane proteins in lipidic mesophases., IEEE Trans. Autom. Sci. Eng., 4, 129, 10.1109/TASE.2006.880541 · doi:10.1109/tase.2006.880541
  67. Peroglio, 2018, Relevance of bioreactors and whole tissue cultures for the translation of new therapies to humans., J. Orthop. Res., 36, 10, 10.1002/jor.23655 · DOI
  68. Petrenko, 2017, The therapeutic potential of three-dimensional multipotent mesenchymal stromal cell spheroids., Stem Cell Res. Ther., 8, 10.1186/s13287-017-0558-6 · DOI · Paper page
  69. Pietsch, 2017, Three-dimensional growth of human endothelial cells in an automated cell culture experiment container during the SpaceX CRS-8 ISS space mission - The SPHEROIDS project., Biomaterials, 124, 126, 10.1016/j.biomaterials.2017.02.005 · DOI
  70. Pigeau, 2018, Commercial scale manufacturing of allogeneic cell therapy., Front. Med., 5, 10.3389/fmed.2018.00233 · DOI
  71. Porterfield, 2000, Oxygen consumption oscillates in single clonal pancreatic beta-cells (HIT)., Diabetes Metab. Res. Rev., 49, 1511
  72. Prasad, 2008, Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes., Blood, 112, 2979, 10.1182/blood-2008-03-140830 · DOI · Paper page
  73. Radio, 2018, Neuronal cell morphology in primary cerebellar granule cells using high-content analysis., Methods Mol. Biol., 1727, 227, 10.1007/978-1-4939-7571-6_17 · doi:10.1007/978-1-4939-7571-6_17
  74. Rawal, 2017, Integration of mesenchymal stem cells into islet cell spheroids improves long-term viability, but not islet function., Islets, 9, 87, 10.1080/19382014.2017.1341455 · DOI
  75. Rothmiller, 2020, Validation of automated pipetting systems for cell culture seeding, exposure and bio-analytical assays in sulfur mustard toxicology., Toxicol. Lett., 320, 80, 10.1016/j.toxlet.2019.12.003 · doi:10.1016/j.toxlet.2019.12.003
  76. Ruiz, 2019, Robust generation of erythroid and multilineage hematopoietic progenitors from human iPSCs using a scalable monolayer culture system., Stem Cell Res., 41, 10.1016/j.scr.2019.101600 · DOI
  77. Schmidhauser, 2019, Gaining insights into the function of post-translational protein modification using genome engineering and molecular cell biology., J. Mol. Biol., 431, 3920, 10.1016/j.jmb.2019.07.015 · DOI
  78. Schrock, 2017, A cost-effectiveness analysis of surgical treatment modalities for chondral lesions of the knee: microfracture, osteochondral autograft transplantation, and autologous chondrocyte implantation., Orthop. J. Sports Med., 5, 10.1177/2325967117704634 · DOI
  79. Schulze-Tanzil, 2020, SV40 transfected human anterior cruciate ligament derived ligamentocytes - Suitable as a human in vitro model for ligament reconstruction?, Int. J. Mol. Sci., 21, 10.3390/ijms21020593 · DOI
  80. Serra, 2019, Scalable culture strategies for the expansion of patient-derived cancer stem cell lines., Stem Cells Int., 2019, 10.1155/2019/8347595 · DOI
  81. Shapiro, 2017, Clinical pancreatic islet transplantation., Nat. Rev. Endocrinol., 13, 268, 10.1038/nrendo.2016.178 · DOI · Paper page
  82. Stephenson, 2018, Recent advances in bioreactors for cell-based therapies., F1000Res., 7, 10.12688/f1000research.12533.1 · DOI
  83. Suszynski, 2016, Oxygenation of the intraportally transplanted pancreatic islet., J. Diabetes Res., 2016, 10.1155/2016/7625947 · DOI · Paper page
  84. Takami, 2018, Hematopoietic stem cell transplantation for acute myeloid leukemia., Int. J. Hematol., 107, 513, 10.1007/s12185-018-2412-8 · doi:10.1007/s12185-018-2412-8
  85. Tsai, 2019, Enhancement of human adipose-derived stem cell spheroid differentiation in an in situ enzyme-crosslinked gelatin hydrogel., J. Mater. Chem. B, 7, 1064, 10.1039/C8TB02835D · DOI
  86. Van Hoof, 2011, Differentiation of human embryonic stem cells into pancreatic endoderm in patterned size-controlled clusters., Stem Cell Res., 6, 276, 10.1016/j.scr.2011.02.004 · DOI · Paper page
  87. Velier, 2019, Validation of a semi automatic device to standardize quantification of Colony-Forming Unit (CFU) on hematopoietic stem cell products., Cytotherapy, 21, 820, 10.1016/j.jcyt.2019.06.005 · doi:10.1016/j.jcyt.2019.06.005
  88. Vlahos, 2019, Endothelialized collagen based pseudo-islets enables tuneable subcutaneous diabetes therapy., Biomaterials, 232
  89. Vormittag, 2018, A guide to manufacturing CAR T cell therapies., Curr. Opin. Biotechnol., 53, 164, 10.1016/j.copbio.2018.01.025 · DOI · Paper page
  90. Wakui, 2017, Method for evaluation of human induced pluripotent stem cell quality using image analysis based on the biological morphology of cells., J. Med. Imaging, 4, 10.1117/1.JMI.4.4.044003 · doi:10.1117/1.jmi.4.4.044003
  91. Watts, 2016, Optimisation and quality control of cell processing for autologous stem cell transplantation., Br. J. Haematol., 175, 771, 10.1111/bjh.14378 · doi:10.1111/bjh.14378
  92. Yamaguchi, 2014, Mesenchymal stem cell spheroids exhibit enhanced in-vitro and in-vivo osteoregenerative potential., BMC Biotechnol., 14, 10.1186/s12896-014-0105-9 · DOI · Paper page
  93. Yaxin, 2011, Robotic liquid handling system for microdispensing of highly viscous reagent, Proceedings of the Third International Conference on Measuring Technology and Mechatronics Automation, 10.1109/ICMTMA.2011.614 · doi:10.1109/icmtma.2011.614
  94. Yoon, 2012, Enhanced cartilage formation via three-dimensional cell engineering of human adipose-derived stem cells., Tissue Eng. A, 18, 1949, 10.1089/ten.tea.2011.0647 · DOI
  95. Zuppinger, 2019, 3D cardiac cell culture: a critical review of current technologies and applications., Front. Cardiovasc. Med., 6, 10.3389/fcvm.2019.00087 · DOI · Paper page

Metadata

Authors
Doulgkeroglou, M.-N., Di Nubila, A., Niessing, B., König, N., Schmitt, R. H., Damen, J., Szilvassy, S. J., Chang, W., Csontos, L., Louis, S., Kugelmeier, P., Ronfard, V., Bayon, Y., & Zeugolis, D. I.
Venue
Frontiers in Bioengineering and Biotechnology
Published
2020-07-14
Volume
8
ISSN
2296-4185
Cited by
98
References
16
Funders
Science Foundation Ireland (15/CDA/3629, 13/RC/2073)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.